Prescription Drug Sucralfate Suspension Recalled for Out-of-Specification Potency
VistaPharm LLC is recalling Sucralfate Oral Suspension 1g/10mL due to out-of-specification assay results. The active ingredient concentration does not meet FDA specifications in approximately 14,400 affected bottles distributed nationwide.
- Product
- SUCRALFATE — SUCRALFATE (SUCRALFATE)
- Category
- Drug
- Distribution
- Distributed nationwide